- 蔚蓝生物 (603739)- 融资性负债

按负债来源分类:发行债券或借贷而来的融资性负债分析

归母股东权益

17.3亿    ,5.4,5.7,9.6,10.3,16.0,16.4,17.1,17.3
了解明细
少数股东权益

1.3亿    ,0.5,0.6,0.7,0.8,0.8,0.9,1.2,1.3
了解明细
负债合计

11.7亿    ,2.9,3.1,2.5,3.4,5.4,8.4,12.1,11.7
了解明细
资产合计

30.3亿    ,8.8,9.5,12.8,14.5,22.2,25.8,30.3,30.3
了解明细



融资性负债

7.5亿    ,0.8,1.1,0.4,0.7,2.4,5.2,7.2,7.5
24.8%
了解明细
经营性负债

4.0亿    ,2.0,1.9,2.0,2.6,2.8,2.9,4.6,4.0
13.2%
了解明细
分配性负债

0.2亿    ,0.1,0.1,0.1,0.1,0.2,0.3,0.3,0.2
0.7%
了解明细



短期借款

6.1亿    ,0.8,1.1,0.4,0.7,1.4,3.7,5.7,6.1
了解明细
一年内到期的非流动负债

0.3亿    ,0,0,0,0,0.0,0,0.9,0.3
了解明细
长期借款

1.0亿    ,0,0,0,0,1.0,1.5,0.6,1.0
了解明细
应付债券

0亿    ,0,0,0,0,0,0,0,0
了解明细
应付利息

0.0亿    ,0,0,0.0,0,0,0,0,0.0
了解明细
交易性金融负债

0亿    ,0,0,0,0,0,0,0,0
了解明细
衍生金融负债

0亿    ,0,0,0,0,0,0,0,0
了解明细